P
0.363
0.00 (0.61%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | ProMIS Neurosciences Inc. | 看涨 | 看跌 |
AIStockmoo 评分
1.0
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.00 |
|
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 27.56% |
| 机构持股比例 | 28.80% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ally Bridge Group (Ny) Llc | 30 Sep 2025 | 6,233,497 |
| Allostery Investments Lp | 30 Jun 2025 | 155,720 |
| Graypoint Llc | 30 Jun 2025 | 52,833 |
| Fiduciary Trust Co | 30 Sep 2025 | 28,583 |
| Howard Financial Services, Ltd. | 30 Sep 2025 | 26,042 |
| 52周波幅 | ||
| 中 | 5.00 (1,277.03%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 18 Nov 2025 | 5.00 (1,277.03%) | 购买 | 0.360 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合